Piramal Pharma Targets USD 2 Billion by FY30
By Rediff Money Desk, New Delhi Sep 25, 2024 16:48
Piramal Pharma aims to become a USD 2 billion global pharma, health and wellness firm by FY30. The company is targeting growth in its CDMO, critical care, and consumer healthcare verticals.
New Delhi, Sep 25 (PTI) Piramal Pharma is aiming to be an over USD 2 billion global pharma, health and wellness firm by FY30, company Chairperson Nandini Piramal said on Wednesday.
In the next five years, the company is targeting its Contract Development and Manufacturing Organisation (CDMO) vertical to become a USD 1.2 billion entity, she told reporters in an interaction.
Besides, the company has set its critical care vertical to touch USD 600 million by FY30 and the consumer healthcare vertical a USD 200 million entity.
Sharing the financial aspirations for the company over the next five years, Piramal said the company is aiming to "double its CDMO revenues, growing at twice the market rate of 6-7 per cent".
This will be driven by integrated services, cross-selling, and differentiated offerings, she added.
For the Complex Hospital Generics (CHG) business, she said the division is targeting "early-teen revenue growth" and will reinforce its position as a global leader in inhalation anaesthesia by expanding coverage in the US and strengthening its presence in markets such as Europe, India, China, and the UK.
For the India Consumer Healthcare (ICH) vertical, Piramal said the company will accelerate power brands expansion and continue building Rs 100-500 crore brands with increased media investment and channel expansion.
The focus will be on core power brands like Lacto Calamine, Little's, and i-Activ, introducing first-to-market propositions and margin-accretive launches, she added.
The ICH vertical is aiming to grow at twice the industry pace in the next five years on the back of omni-channel expansion, e-commerce profitability, and a sharper focus on building power brands, Piramal said.
In the next five years, the company is targeting its Contract Development and Manufacturing Organisation (CDMO) vertical to become a USD 1.2 billion entity, she told reporters in an interaction.
Besides, the company has set its critical care vertical to touch USD 600 million by FY30 and the consumer healthcare vertical a USD 200 million entity.
Sharing the financial aspirations for the company over the next five years, Piramal said the company is aiming to "double its CDMO revenues, growing at twice the market rate of 6-7 per cent".
This will be driven by integrated services, cross-selling, and differentiated offerings, she added.
For the Complex Hospital Generics (CHG) business, she said the division is targeting "early-teen revenue growth" and will reinforce its position as a global leader in inhalation anaesthesia by expanding coverage in the US and strengthening its presence in markets such as Europe, India, China, and the UK.
For the India Consumer Healthcare (ICH) vertical, Piramal said the company will accelerate power brands expansion and continue building Rs 100-500 crore brands with increased media investment and channel expansion.
The focus will be on core power brands like Lacto Calamine, Little's, and i-Activ, introducing first-to-market propositions and margin-accretive launches, she added.
The ICH vertical is aiming to grow at twice the industry pace in the next five years on the back of omni-channel expansion, e-commerce profitability, and a sharper focus on building power brands, Piramal said.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 10.41 (+ 0.48)
- 53727067
- GTL Infrastructure
- 2.41 (+ 4.78)
- 49996392
- Five-Star Business F
- 797.20 ( -1.39)
- 47756593
- Spicejet Ltd.
- 61.84 ( -0.87)
- 37121295
- Reliance Power L
- 44.16 (+ 4.99)
- 36538149
MORE NEWS
Gulf Oil Promoter Sells 4% Stake for Rs 263 Crore
Gulf Oil International Mauritius Inc. sold a 4% stake in Gulf Oil Lubricants India for...
Zaggle Acquires Stakes in Span Across IT &...
Fintech firm Zaggle invests Rs 48 crore in Span Across IT Solutions and Mobileware...
Swiggy Files Updated IPO Papers: Eyes Rs 3,750 Cr
Swiggy files updated IPO papers with Sebi, aiming to raise Rs 3,750 crore through fresh...